North
America leads the global erectile dysfunction market and according to
recent studies the region will continue to remain the largest market
for erectile dysfunction drugs such as Cialis and Viagra over the
next few years. While factors such as an increase in geriatric
population and growing preference towards a sedentary lifestyle is
expected to create an increased demand for erectile dysfunction
drugs, the market on the whole might suffer a backlash owing to the
rising incidence of sexually transmitted diseases and growing threat
of counterfeit drugs.
Browse
the full report with complete TOC at Erectile Dysfunction Drugs
Market
http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html
According
to a recent research conducted to study the incumbent trends, the
global erectile dysfunction drugs market, worth US$4.3 billion in
2012, is anticipated to reach US$3.4 billion by the end of 2019,
registering decline at a CAGR of -4.5% between 2013 and 2019.
Erectile
dysfunction is a condition in men that defines their inability to
attain penile erection. It is a common medical disorder that
primarily affects men above the age of 40 years. Men suffering from
diabetes and hypertension might also face the problem of erectile
dysfunction. Apart from this, there are many lifestyle-related
factors such as smoking, obesity, excessive consumption of alcohol,
drug addiction, and poor physical and psychological health that can
trigger the condition of erectile dysfunction among men.
Patent
Expiration of Major Pharmaceutical Giants to Hinder Growth in Global
Erectile Dysfunction Drugs Market
Request
for customization of this report
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550
The
global market for erectile dysfunction drugs is on the verge of
suffering a huge setback. Industry experts are of the view that the
global demand for erectile dysfunction drugs will decline drastically
before 2019 ends. The market suffered its first jolt with the end
patent exclusivity granted to Viagra in the U.S. in 2013. Moreover,
patent exclusivities for Levitra by Bayer AG and Cialis by Eli Lilly
& Co are also slated to end by 2019, which would further cut down
the revenue of the global erectile dysfunction drugs market. Generic
manufacturers will benefit the most from the resultant vacuum. They
will have a chance to claim the major share of the global market by
launching personalized versions of these brands. Apart from this, the
low rate of success registered by novel drug formulations also
account for the slump that the global erectile dysfunction drugs
market is projected to witness.
Viagra
Will Maintain Major Revenue Share Due to Extended Exclusivity
Browse
Press Release Erectile Dysfunction Drugs Market
http://www.transparencymarketresearch.com/pressrelease/erectile-dysfunction-drugs.htm
Viagra
accounted for 45% of the total revenue earned by the global erectile
dysfunction drugs market in 2012. However, the overall market revenue
for erectile dysfunction drug is anticipated to decline rapidly owing
to the loss of the drug’s patent exclusivity in Europe and many
other major markets. However, the extended lease of life granted to
Viagra will help it maintain strong revenue until 2020, whereas the
global market for the second-largest contributor, Cialis, is
projected to decline at a CAGR of 12.6% from a value of US$1,926.8
million in 2012, since its patent exclusivity will expire sooner, in
2017. In addition to this, the patent exclusivity for Bayer’s
Levitra is also slated to expire in 2018, which will bring down the
revenue for the global erectile dysfunction drug market even further.
North
America to Continue to Dominate Global Erectile Dysfunction Drug
Market
Article
Erectile Dysfunction Drugs Market
http://www.transparencymarketresearch.com/article/erectile-dysfunction-drugs.htm
On
the basis of revenue, North America dominated the global erectile
dysfunction drugs market in 2012 and is anticipated to continue its
run as the market leader in the forthcoming years. The extended
patent exclusivity granted to Viagra in the U.S. till 2020 will help
the region maintain its position as the market leader over the next
couple of years. The increase in demand for erectile dysfunction
drugs had helped Europe emerge as the second largest regional market
in 2012.
Global
Market Leaders
The
global market for erectile dysfunction drugs is primarily dominated
by companies such as Eli Lilly & Co, Pfizer Inc., Bayer AG, Vivus
Inc., and Dong-A Pharmaceutical Co Ltd
Browse
all Pharmaceutical Market Research Reports @
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About
Us
Transparency
Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our
data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research
material for business reports.
Contact:
Nachiket
90
State Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA/Canada
Toll Free: 866-552-3453
No comments:
Post a Comment